These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27417557)

  • 21. Microalbuminuria in essential hypertension.
    Mimran A; Ribstein J; Du Cailar G
    Curr Opin Nephrol Hypertens; 1999 May; 8(3):359-63. PubMed ID: 10456269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension.
    Leoncini G; Viazzi F; Parodi D; Vettoretti S; Ratto E; Ravera M; Tomolillo C; Del Sette M; Bezante GP; Deferrari G; Pontremoli R
    Hypertension; 2003 Jul; 42(1):14-8. PubMed ID: 12756221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure control is similar in treated hypertensive patients with optimal or with high-normal albuminuria.
    Oliveras A; Armario P; Lucas S; de la Sierra A;
    Am J Hypertens; 2014 Sep; 27(9):1185-90. PubMed ID: 24646879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular permeability, blood pressure, and organ damage in primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Parodi A; Falqui V; Conti N; Tomolillo C; Ravera G; Deferrari G; Pontremoli R
    Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent insights in the development of organ damage caused by hypertension.
    Persu A; De Plaen JF
    Acta Cardiol; 2004 Aug; 59(4):369-81. PubMed ID: 15368798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Masked hypertension and target organ damage in treated hypertensive patients.
    Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y
    Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microalbuminuria: a useful marker of cardiovascular disease.
    Jarraya F; Lakhdar R; Kammoun K; Mahfoudh H; Drissa H; Kammoun S; Abid M; Hachicha J
    Iran J Kidney Dis; 2013 May; 7(3):178-86. PubMed ID: 23689147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection and management of the high-risk patient with elevated blood pressure.
    Sierra C; de la Sierra A
    Vasc Health Risk Manag; 2008; 4(2):289-96. PubMed ID: 18561504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study.
    Färbom P; Wahlstrand B; Almgren P; Skrtic S; Lanke J; Weiss L; Kjeldsen S; Hedner T; Melander O
    Hypertension; 2008 Jul; 52(1):115-22. PubMed ID: 18504324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
    Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
    J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microalbuminuria, cardiovascular, and renal risk in primary hypertension.
    Pontremoli R; Leoncini G; Ravera M; Viazzi F; Vettoretti S; Ratto E; Parodi D; Tomolillo C; Deferrari G
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S169-72. PubMed ID: 12466308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of renal resistive index with target organ damage in essential hypertension.
    Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
    Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach.
    Leoncini G; Sacchi G; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2002 Jul; 20(7):1315-21. PubMed ID: 12131528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of microalbuminuria and ECG left ventricular hypertrophy in hypertensive patients in private practices in South Africa.
    Rayner B; Becker P
    Cardiovasc J S Afr; 2006; 17(5):245-9. PubMed ID: 17117229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal volume in children with ADPKD: size matters.
    Chapman AB; Guay-Woodford LM
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):698-9. PubMed ID: 19339418
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.
    Assadi F
    Pediatr Cardiol; 2007; 28(1):27-33. PubMed ID: 17308944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age.
    Palatini P; Mos L; Santonastaso M; Saladini F; Benetti E; Mormino P; Bortolazzi A; Cozzio S
    J Womens Health (Larchmt); 2011 Aug; 20(8):1175-81. PubMed ID: 21702688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination?
    Cuspidi C; Macca G; Salerno M; Michev L; Fusi V; Severgnini B; Corti C; Meani S; Magrini F; Zanchetti A
    Ital Heart J; 2001 Sep; 2(9):702-6. PubMed ID: 11666100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.